[Federal Register Volume 72, Number 46 (Friday, March 9, 2007)]
[Notices]
[Pages 10774-10775]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 07-1095]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Arthritis and Musculoskeletal and Skin 
Diseases, Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Arthritis and 
Musculoskeletal and Skin

[[Page 10775]]

Diseases Special Emphasis Panel; Women's Health and Osteoporosis.
    Date: March 13, 2007.
    Time: 11 a.m. to 1 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, One Democracy Plaza, 6701 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Charles H. Washabaugh, PhD., Scientific Review 
Administrator, Review Branch, NIAMS/NIH, 6701 Democracy Blvd., Room 
816, Bethesda, MD 20892, 301-594-1501, <a href="/cdn-cgi/l/email-protection#295e485a41484b484a694448404507474041074e465f"><span class="__cf_email__" data-cfemail="cfb8aebca7aeadaeac8fa2aea6a3e1a1a6a7e1a8a0b9">[email protected]</span></a>.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.
    Name of Committee: National Institute of Arthritis and 
Musculoskeletal and Skin Diseases Special Emphasis Panel; Clinical 
Trial Planning.
    Date: March 26, 2007.
    Time: 10 a.m. to 12 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Democracy Blvd., 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Kan Ma, PhD., Scientific Review Administrator, 
NIH/NIAMS, EP Review Branch, One Democracy Plaza, Suite 800, 
Bethesda, MD 20892-4872, 301-594-4952, <a href="/cdn-cgi/l/email-protection#d7bab6bce597bab6bebbf9b9bebff9b0b8a1"><span class="__cf_email__" data-cfemail="026f636930426f636b6e2c6c6b6a2c656d74">[email protected]</span></a>.
    Name of Committee: National Institute of Arthritis and 
Musculoskeletal and Skin Diseases Special Emphasis Panel; Orthopedic 
Clinical Trial.
    Date: March 27, 2007.
    Time: 12 p.m. to 2 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, One Democracy Plaza, 6701 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Michael L. Bloom, PhD,, Scientific Review 
Administrator, EP Review Branch, NIH-NIAMS Institute, One Democracy 
Plaza, Room 820, MSC 4872, 6701 Democracy Blvd., Bethesda, MD 20892-
4872, 301-594-4953, <a href="/cdn-cgi/l/email-protection#0d40646e656c6861524f616262604d636465236a627b"><span class="__cf_email__" data-cfemail="763b1f151e17131a29341a19191b36181f1e58111900">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.846, 
Arthritis, Musculoskeletal and Skin Diseases Research, National 
Institutes of Health, HHS.)

    Dated: March 2, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-1095 Filed 3-8-07; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>